Skip to main content
SpringerLink
Log in

Calcium Antagonists and Cancer: Causation or Association?

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.

    PubMed  Google Scholar 

  2. Pahor M, Guralnik JM, Corti C, Foley DJ, Carbonin PU, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43: 1191-1197.

    PubMed  Google Scholar 

  3. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.

    PubMed  Google Scholar 

  4. Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): A randomized controlled trial. JAMA 1996;276:785-791.

    PubMed  Google Scholar 

  5. Wagenknecht LE, Furberg CD, Hammon JW, Legault C, Troost BT. Surgical bleeding: Unexpected effect of a calcium antagonist. Br Med J 1995;310:776-777.

    Google Scholar 

  6. Zuccala G, Pahor M, Landi F, et al. Use of calcium antagonists and need for perioperative transfusion in older patients with hip fracture: Observational study. Br Med J 1997;314:643-644.

    Google Scholar 

  7. Pahor M, Guralnik JM, Furberg CD, Carbonin PU, Havlik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996;347:1061-1065.

    Article  PubMed  Google Scholar 

  8. Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996;9:695-699.

    Article  Google Scholar 

  9. Pahor M, Guralnik JM, Ferrucci L, et al. Calcium channel blockade and incidence of cancer in aged populations. Lancet 1996;348:493-497.

    PubMed  Google Scholar 

  10. Jick H, Jick S, Derby LE, Vasilakis C, MyersMW, Meier CR. Calcium channel blockers and risk of cancer. Lancet 1997;349:525-528.

    Article  PubMed  Google Scholar 

  11. Hardell L, Fredrikson M, Axelson O. Case-control study on colon cancer regarding previous diseases and drug intake. Int J Oncol 1996;8:439-444.

    Google Scholar 

  12. Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 1997;80:1439-1447.

    Article  Google Scholar 

  13. Daling JR. Calcium channel blockers and cancer: Is an association biologically plausible? Am J Hypertens 1996;9: 713-714.

    Article  PubMed  Google Scholar 

  14. Li LH, Wine RN, Miller DS, Reece JM, Smith M, Chapin RE. Protection against methoxyacetic-acid-induced spermatocyte apoptosis with calcium channel blockers in cultured rat seminiferous tubules: Possible mechanisms. Toxicol Appl Pharmacol 1997;144:105-119.

    Article  PubMed  Google Scholar 

  15. Correale P, Tagliaferri P, Celio L, Genua G, Montagnani S, Bianco AR. Verapamil upregulates sensitivity of human colon and breast cancer cells to LAK-cytotoxicity in vitro. Eur J Cancer 1991;27:1393-1395.

    PubMed  Google Scholar 

  16. Pahor M, Kritchevsky SB, Zuccala' G, Guralnik JM. Diabetes and risk of adverse events with calcium antagonists. Diabetes Care 1998;21:193-194.

    PubMed  Google Scholar 

  17. Braun S, Boyko V, Behar S, et al. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J Am Coll Cardiol 1998;31:804-808.

    Article  PubMed  Google Scholar 

  18. Hole DJ, Gillis CR, McCallum IR, et al. Cancer risk of hypertensive patients taking calcium antagonists. J Hypertens 1998;16:119-124.

    Article  PubMed  Google Scholar 

  19. Jonas M, Goldbourt U, Boyko V, Mandelzweig L, Behar S, Reicher-Reiss H. Nifedipine and cancer mortality: Ten-year follow-up of 2607 patients after acute myocardial infarction. Cardiovasc Drugs Ther 1998;12:177-181.

    Article  PubMed  Google Scholar 

  20. Rosenberg L, Rao RS, Palmer JR, et al. Calcium channel blockers and the risk of cancer. JAMA 1998;279:1000-1004.

    PubMed  Google Scholar 

  21. Olsen JH, Sorensen HT, Friis S, et al. Cancer risk in users of calcium channel blockers. Hypertension 1997;29: 1091-1094.

    PubMed  Google Scholar 

  22. The Israeli Sprint Study Group. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group. Eur Heart J 1988;9:354-364.

    Google Scholar 

  23. Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179-184.

    Article  PubMed  Google Scholar 

  24. Pahor M, Furberg CD. Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies. Drugs Aging 1998;13:99-108.

    PubMed  Google Scholar 

  25. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-764.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Preventive Medicine, University of Tennessee, Memphis, Tennessee, USA

    Marco Pahor & Curt D. Furberg

  2. Department of Public Health Sciences, Wake Forest School of Medicine, Winston Salem, North Carolina, USA

    Marco Pahor & Curt D. Furberg

Authors
  1. Marco Pahor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Curt D. Furberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pahor, M., Furberg, C.D. Calcium Antagonists and Cancer: Causation or Association?. Cardiovasc Drugs Ther 12, 511–513 (1998). https://doi.org/10.1023/A:1007706529684

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007706529684

Search

Navigation